Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The latest news, stories and exciting findings from across the Oxford cancer research community

University's RadCam library highlighted in yellow

MILI trial: the start of precision cancer prevention

Oxford’s first precision prevention cancer trial in people with Li Fraumeni Syndrome will also shed light on the mechanisms of cancer development in the general population

Congratulations to Cancer Science DPhil Student, Giampiero Valenzano: voted lead scientist of ‘I’m a Scientist’s’ Cancer Zone

‘I’m a Scientist’ is a student-led STEM enrichment activity, which connects school students with scientists through energetic, real-time text-based chats.

Disentangling a long-standing link between inflammation and cancer progression

A study led by the Mead Group has demonstrated a previously unknown effect of chronic inflammation on TP53-mutant blood stem cells, shedding light on the progression of leukaemia.

What matters most to people with primary liver cancer?

Oxford Cancer will host workshop on patient priorities for those with HCC (hepato-cellular carcinoma).

New Study Offers Hope in Early Detection of Breast Cancer

A team of researchers led by the Nuffield Department of Primary Care Health Sciences, have developed a new model that reliably predicts a woman's likelihood of developing and then dying of breast cancer within a decade.

Save the date for the 2024 Oxford Cancer Symposium!

The CRUK Oxford Centre - Oxford Cancer Symposium is the crowning event in the Oxford Cancer calendar. With approximately 300 people attending in person each year, it provides an opportunity for our members to network and build new collaborations.

Double funding success to improve detection and risk classification of myeloproliferative neoplasms (MPNs)

Blood Cancer UK and Cancer Research UK recognise the need and impact of artificial intelligence approaches developed by Professor Daniel Royston and Professor Jens Rittscher for early detection and assessment of blood cancers.

Identification of a molecular signature that correlates with patient prognosis in SETD2-mutated cancers

In a pan-cancer analysis spanning 24 different cancer types, researchers shed light on the relationship between SETD2, DNA methylation and cancer development.

Ludwig Oxford’s Richard White receives 2023 Outstanding Research award from the Society for Melanoma Research

Richard White has received the 2023 Outstanding Research award from the Society for Melanoma Research.

New tool to predict people’s risks of getting oesophageal cancer

A new study from Professor Julia Hippisley-Cox and colleagues offers hope for the earlier detection of oesophageal cancer.

NIHR to fund new Policy Research Unit on Cancer Research

The National Institute for Health and Care Research (NIHR) has announced a major investment in its Policy Research Units (PRUs). Researchers in the Nuffield Department of Primary Care Health Sciences at Oxford will play a key role in a new Unit focusing on the early detection of cancer.

Population-scale digital capabilities can protect cancer patients at risk of COVID

Research led by the Nuffield Department of Medicine has been published in Nature Scientific Reports, investing the effect of COVID-19 across the cancer population over the course of the pandemic. This analysis is the world’s largest and most comprehensive cancer evaluation showcasing the United Kingdom’s digital capabilities and the potential of population-scale cancer studies.

Children’s Cancer and Leukaemia Group Funding for Anindita Roy

New research, led by Professor Anindita Roy, is to be funded by families affected by childhood cancer through Children’s Cancer and Leukaemia Group (CCLG)'s Special Named Fund programme.

Oxford to launch UK’s first trials unit dedicated to conducting precision prevention and early detection studies

Oxford researchers have been given a £1 million boost to support their strategy of developing cancer prevention treatments and early diagnostic tools for people at high risk of cancer.

New study to investigate breast cancer in ethnic minority groups

A new research project, led by Dr Toral Gathani and funded by Cancer Research UK, aims to shed light on the variation in breast cancer in different ethnic minority groups.

Tumour monocyte content can predict immunochemotherapy outcomes, study shows

A team of Oxford researchers has discovered a link between immune cells known as monocytes in tumours and overall survival in patients with oesophageal cancer.

Oxford Cancer Immuno-Oncology Network Launched

We were delighted to officially launch our Oxford Cancer Immuno-Oncology Network on the 23rd of June, with over 100 people in attendance and the luxury of convening at the Ashmolean Museum.

Researchers discover how cancer cells adapt under acidity

New research led by Dr Johanna Michl and Professor Pawel Swietach has solved the longstanding mystery of how cancer cells are able to maintain a relatively alkaline intracellular pH, despite being surrounded by an acidic environment.

Professor David Hunter appointed as a Companion of the Order of Australia

David Hunter, Richard Doll Professor of Epidemiology and Medicine at Oxford Population Health, has been appointed as a Companion of the Order of Australia in the Australian King’s Birthday Honours List.

Women diagnosed with early breast cancer today are much less likely to die from the disease than 20 years ago

A study conducted by researchers at Oxford Population Health has found that women who are diagnosed with early stage breast cancer today are 66% less likely to die from the disease within five years of diagnosis than they were 20 years ago.

Load More